Reproducibility of magnetic resonance spectroscopy in correlation with signal-to-noise ratio
暂无分享,去创建一个
Yuji Nakamoto | Nobuo Kohara | Tomohisa Okada | Michio Senda | Setsu Sakamoto | M. Senda | Y. Nakamoto | S. Sakamoto | T. Okada | N. Kohara
[1] R. Kreis,et al. Effects of physiologic motion of the human brain upon quantitative 1H‐MRS: analysis and correction by retro‐gating , 1998, NMR in biomedicine.
[2] W M Brooks,et al. Reproducibility of 1H‐MRS in vivo , 1999, Magnetic resonance in medicine.
[3] P. Pattany,et al. Effects of physiologic human brain motion on proton spectroscopy: quantitative analysis and correction with cardiac gating. , 2002, AJNR. American journal of neuroradiology.
[4] P G Webb,et al. Automated single‐voxel proton MRS: Technical development and multisite verification , 1994, Magnetic resonance in medicine.
[5] C. Lyketsos,et al. Long-term outcomes of galantamine treatment in patients with Alzheimer disease. , 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[6] E Adalsteinsson,et al. Motion correction and lipid suppression for 1H magnetic resonance spectroscopy , 2000, Magnetic resonance in medicine.
[7] R. Moats,et al. Evaluation of automated MR spectroscopy: application in Alzheimer disease. , 1995, AJNR. American journal of neuroradiology.
[8] R. Menon,et al. Comparison of the quantification precision of human short echo time 1H spectroscopy at 1.5 and 4.0 Tesla , 2000, Magnetic resonance in medicine.
[9] M Slifstein,et al. Validation and Reproducibility of Measurement of 5-HT1A Receptor Parameters with [carbonyl-11C]WAY-100635 in Humans: Comparison of Arterial and Reference Tissue Input Functions , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] D M Doddrell,et al. A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. , 1999, Magnetic resonance imaging.
[11] Douglas L. Rothman,et al. In vivo detection and quantification of scalar coupled H NMR resonances , 2001 .
[12] P. Williamson,et al. The use of a priori knowledge to quantify short echo in vivo 1h mr spectra , 1995, Magnetic resonance in medicine.
[13] P. Allen,et al. Motional degradation of metabolite signal strengths when using STEAM: A correction method , 1992, NMR in biomedicine.
[14] Xin Yu,et al. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. , 2003, The American journal of psychiatry.
[15] E G Tangalos,et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.
[16] B D Ross,et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. , 1995, Radiology.
[17] T. Ogino,et al. Reproducibility of short echo time proton magnetic resonance spectroscopy using point-resolved spatially localized spectroscopy sequence in normal human brains. , 1999, Radiation medicine.
[18] B. Ross,et al. Added Value of Automated Clinical Proton MR Spectroscopy of the Brain , 1995, Journal of computer assisted tomography.
[19] G Helms,et al. Restoration of motion‐related signal loss and line‐shape deterioration of proton MR spectra using the residual water as intrinsic reference , 2001, Magnetic resonance in medicine.
[20] B D Ross,et al. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. , 1993, Radiology.
[21] I. Marshall,et al. Reproducibility of metabolite peak areas in 1H MRS of brain. , 1996, Magnetic resonance imaging.
[22] J. Frahm,et al. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.
[23] Juan Bustillo,et al. Reproducibility of 1H‐MRS measurements in schizophrenic patients , 2003, Magnetic resonance in medicine.
[24] T. Ernst,et al. Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease , 1994, Magnetic resonance in medicine.
[25] G. Elbel,et al. Phase coherent averaging in magnetic resonance spectroscopy using interleaved navigator scans: Compensation of motion artifacts and magnetic field instabilities , 2002, Magnetic resonance in medicine.